This Beaten-Down AI Stock Could Stage a Comeback in 2026

Salesforce shares plunged roughly 33.7% over the past 12 months after missing revenue-growth expectations, yet the company remains profitable and growing: Q3 2025 revenue rose 9% year‑over‑year, gross margin was 78%, operating margin 22%, and operating cash flow increased 17%. The firm carries $11.6 billion of debt and $7.2 billion in cash and is trading at a P/E of 34.7 versus Microsoft at 36.8 and Oracle at 37.9, a valuation the author views as putting Salesforce in line with peers and potentially primed for a rebound in 2026.

Analysis

Market structure: Salesforce’s 33.7% drawdown primarily benefits competitors with steadier growth narratives (MSFT, ORCL) and pure-play AI vendors that can claim higher marginal growth; enterprise buyers gain leverage in renewal negotiations. Valuation parity (CRM P/E 34.7 vs MSFT 36.8 and ORCL 37.9) signals a re‑rating window where share gains will come from execution and guidance beats rather than multiple expansion alone. Cross-asset: expect near-term equity vol uplift for large-cap software, modest bid for IG tech credit and no immediate commodity/FX shifts; 10Y and credit spreads could tighten if tech demand stabilizes.

Risks: Tail risks include a major data/privacy/regulatory hit (fines or restrictive AI rules) and a macro-driven enterprise spending pullback that would compress ARR growth by >5% YoY; operationally, AI model failures or lost anchor accounts could shave 200–400bp off growth. Time horizons matter: days—elevated intraday vol and put-buying; weeks—guidance/renewal cadence will move shares; 12–24 months—AI adoption could restore 30–60% upside if ARR growth re-accelerates. Hidden dependencies include large-account renewals, partner integrations and salesforce execution on upsells.

Trade implications: Direct: establish a 2–3% long position in CRM now, scale to 5% if the stock drops another 10–15% within 3 months, target 12–36 month hold for 40–60% upside if multiples normalize. Pair: long CRM (2%) / short PLTR (1%) for 3–12 months to capture quality gap and weaker sentiment vs CRM. Options: buy a 9–12 month CRM call spread (buy ATM, sell 20–25% OTM) to cap cost; alternatively sell 3–6 month cash‑secured puts 10–15% OTM to collect premium and pick up shares if weakness occurs.

Contrarian angles: The market treats a modest 9% revenue growth miss as structural decay—consensus missing that CRM still has 78% gross margins and strong OCF (17% YoY). Reaction looks at least partially overdone: if CRM preserves ARR and upgrades AI tooling, a 12–24 month multiple reversion to peer median would justify current long. Unintended consequences: crowded put-selling or a positive large‑account renewal could trigger a short squeeze; conversely, prolonged multiple compression is the main risk and merits active size/funding management.

Key Decisions for Investors

• Establish a 2–3% long position in CRM (deployed over 2–4 tranches) today; add to a 5% position if CRM falls a further 10–15% within the next 3 months. Target horizon 12–36 months, target upside 40–60% if ARR re-accelerates and P/E reverts to peer median.
• Implement a pair trade: long CRM (2% notional) / short PLTR (1% notional) for 3–12 months to exploit CRM’s superior margins and client base vs Palantir’s weaker sentiment; rebalance if PLTR outperforms by >15%.
• Use options to control risk: buy a 9–12 month CRM call spread (buy ATM, sell 20–25% OTM) sized to equal the 2% notional long for leveraged upside with defined max loss; alternatively sell 3–6 month cash‑secured puts 10–15% OTM to collect premium and acquire shares at a discount.
• Reduce 5–10% exposure to momentum AI/momentum software names in favor of quality SaaS (CRM, MSFT) and maintain a 3‑month tail hedge (S&P put spread) if holding directional long exposure through upcoming earnings/guidance windows.